1
|
Plasma Protein Binding Refinement of the Extended Clearance Classification System: Subclasses for Predicting Hepatic Uptake or Renal Clearance for Classes 1B and 3B. Eur J Drug Metab Pharmacokinet 2023; 48:63-73. [PMID: 36441468 DOI: 10.1007/s13318-022-00806-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/02/2022] [Indexed: 11/29/2022]
Abstract
BACKGROUND AND OBJECTIVES The Extended Clearance Classification System (ECCS) was established to facilitate the timely anticipation of clearance rate determination according to the physicochemical characteristics of a given compound and in vitro passive membrane permeability. Unfortunately, distinguishing between renal and hepatic uptake clearance mechanisms using ECCS class 3B is not possible. We determined the effects of plasma protein binding (PPB) on major hepatic organic anion transporting polypeptide (OATP) and renal organic anion transporter (OAT) substrates. A modified ECCS could predict when renal or hepatic uptake mechanisms were the main clearance rate determinants (accounting for ≥ 70% of total clearance). METHODS A dataset of 66 human OATP and 41 OAT substrates was analyzed to determine the effect of PPB. A total of 63 acidic and zwitterionic, and high-molecular-weight (MW > 400 Da) compounds, including 50 drugs in ECCS classes 1B and 3B, were reanalyzed considering their PPB. RESULTS Statistical analyses revealed that hepatic uptake transporter (OATP1B1 and OATP1B3) substrates possess a high PPB rate of ≥ 90%, whereas OAT1 and/or OAT3 substrates possess low PPB rates of < 90%. By analyzing the 63 drugs on the basis of their PPB, the active hepatic uptakes of acids and zwitterions were determined to be the main clearance mechanisms, with PPB ≥ 90%, whereas renally eliminated drugs exhibited limited PPB (< 90%). CONCLUSIONS Therefore, PPB is an effective parameter for defining clearance rate determination for acidic and zwitterionic drugs with high MWs. Using PPB as an additional parameter in ECCS, clearance mechanisms for class 1B and 3B compounds can be predicted, and OATP and OAT substrates may be readily distinguished.
Collapse
|
2
|
Sharifi S, Caracciolo G, Mahmoudi M. Biomolecular Corona Affects Controlled Release of Drug Payloads from Nanocarriers. Trends Pharmacol Sci 2020; 41:641-652. [DOI: 10.1016/j.tips.2020.06.011] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2020] [Revised: 06/29/2020] [Accepted: 06/30/2020] [Indexed: 12/12/2022]
|
3
|
Dargó G, Bajusz D, Simon K, Müller J, Balogh GT. Human Serum Albumin Binding in a Vial: A Novel UV-pH Titration Method To Assist Drug Design. J Med Chem 2020; 63:1763-1774. [PMID: 31995375 PMCID: PMC7307925 DOI: 10.1021/acs.jmedchem.0c00046] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
![]()
The knowledge on human serum albumin
(HSA) binding is of utmost
importance as it affects pharmacokinetic behavior and bioavailability
of drugs. In this article, we report a novel method to screen for
ionizable molecules with high HSA binding affinity based on pKa shifts using UV-pH titration. We investigated
the HSA binding of 27 drugs and compared the results to experimental
data from conventional methods. In most cases, significant shifts
(ΔpKa > 0.1) were observed for
drugs
with high HSA binding, while no change could be detected for low-affinity
binders. We showed the pivotal role of ionization centers in the formation
of strong interactions between drug and HSA using molecular docking
studies. We also verified our findings by testing five modified analogues
designed by structural considerations. Significant decreases in their
HSA binding proved that the UV-pH titration method combined with an
in silico support can be used as a medicinal chemistry tool to assist
rational molecular design.
Collapse
Affiliation(s)
- Gergő Dargó
- Department of Chemical and Environmental Process Engineering , Budapest University of Technology and Economics , Műegyetem rakpart 3 , 1111 Budapest , Hungary.,Chemistry Department , Gedeon Richter Plc. , Gyömrői út. 19-21 , 1107 Budapest , Hungary
| | - Dávid Bajusz
- Medicinal Chemistry Research Group , Research Centre for Natural Sciences , Magyar tudósok krt. 2 , 1117 Budapest , Hungary
| | - Kristóf Simon
- Department of Organic Chemistry and Technology , Budapest University of Technology and Economics , Műegyetem rakpart 3 , 1111 Budapest , Hungary
| | - Judit Müller
- Medicinal Chemistry Laboratory II , Gedeon Richter Plc. , Gyömrői út. 19-21 , 1107 Budapest , Hungary
| | - György T Balogh
- Department of Chemical and Environmental Process Engineering , Budapest University of Technology and Economics , Műegyetem rakpart 3 , 1111 Budapest , Hungary.,Chemistry Department , Gedeon Richter Plc. , Gyömrői út. 19-21 , 1107 Budapest , Hungary.,Department of Pharmacodynamics and Biopharmacy , University of Szeged , 6720 Szeged , Hungary
| |
Collapse
|
4
|
Jia X, Liu J, Shi B, Liang Q, Gao J, Feng G, Chang Z, Li Q, Zhang X, Chen J, Zhao X. Screening Bioactive Compounds of Siraitia grosvenorii by Immobilized β 2-Adrenergic Receptor Chromatography and Druggability Evaluation. Front Pharmacol 2019; 10:915. [PMID: 31474867 PMCID: PMC6707405 DOI: 10.3389/fphar.2019.00915] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2019] [Accepted: 07/19/2019] [Indexed: 12/17/2022] Open
Abstract
As the first and key step of traditional Chinese medicine (TCM)-guided drug development, lead discovery necessitates continuous exploration of new methodology for screening bioactive compounds from TCM. This work intends to establish a strategy for rapidly recognizing β2-adrenergic receptor (β2-AR) target compounds from the fruit of Siraitia grosvenorii (LHG). The method involved immobilization of β2-AR onto amino-microsphere to synthesize the receptor column, the combination of the column to high-performance liquid chromatography (HPLC) to screen bioactive compounds of LHG, the identification of the compounds by HPLC coupled with mass spectrometry (MS), and the evaluation of druggability through pharmacokinetic examination by HPLC-MS/MS. Mogroside V was screened and identified as the β2-AR-targeted bioactive compounds in LHG. This compound exhibited desired pharmacokinetic behavior including the time to reach peak plasma concentrations of 45 min, the relatively low elimination of 138.5 min, and the high bioavailability. These parameters indicated that mogroside V has a good druggability for the development of new drugs fighting β2-AR-mediated respiratory ailments like asthma. The combination of the methods in this work is probably becoming a powerful strategy for screening and early evaluating the bioactive compounds specifically binding to G-protein-coupled receptor target from complex matrices including TCM.
Collapse
Affiliation(s)
- Xiaoni Jia
- Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, College of Life Sciences, Northwest University, Xi’an, China
- Department of Pharmacy, Xi ‘an Mental Health Center, Xi’an, China
| | - Jiajun Liu
- Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, College of Life Sciences, Northwest University, Xi’an, China
| | - Baimei Shi
- Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, College of Life Sciences, Northwest University, Xi’an, China
| | - Qi Liang
- Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, College of Life Sciences, Northwest University, Xi’an, China
- College of Chemistry & Chemical Engineering, Xi ‘an Shiyou University, Xi’an, China
| | - Juan Gao
- Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, College of Life Sciences, Northwest University, Xi’an, China
| | - Gangjun Feng
- Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, College of Life Sciences, Northwest University, Xi’an, China
| | - Zhongman Chang
- Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, College of Life Sciences, Northwest University, Xi’an, China
| | - Qian Li
- Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, College of Life Sciences, Northwest University, Xi’an, China
| | - Xiaohong Zhang
- Department of Pharmacy, Xi ‘an Mental Health Center, Xi’an, China
| | - Jianbo Chen
- Department of Pharmacy, Xi ‘an Mental Health Center, Xi’an, China
| | - Xinfeng Zhao
- Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, College of Life Sciences, Northwest University, Xi’an, China
| |
Collapse
|
5
|
Subudhi BB, Sahu PK, Singh VK, Prusty S. Conjugation to Ascorbic Acid Enhances Brain Availability of Losartan Carboxylic Acid and Protects Against Parkinsonism in Rats. AAPS JOURNAL 2018; 20:110. [PMID: 30350232 DOI: 10.1208/s12248-018-0270-1] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/23/2018] [Accepted: 10/02/2018] [Indexed: 11/30/2022]
Abstract
Identification of renin-angiotensin system in the interplay of hypertension and neurodegeneration has paved the way for the repurposing of antihypertensive drugs against Parkinsonism. Losartan carboxylic acid (LCA), the potent AT1 blocker metabolite of losartan, suffers from poor bioavailability and brain access. Since ascorbate transporters have earlier shown enough flexibility as carriers, we have conjugated losartan carboxylic acid to ascorbic acid with the aim of achieving higher oral/brain availability. Ester of LCA and ascorbic acid (FED) was developed keeping in view the substrate specificity of ascorbate transporters. Oral/brain bioavailability was assessed using in vivo pharmacokinetic model. Effect on central nervous system (CNS) and protection against Parkinsonism was evaluated using in vivo models. FED enhanced bioavailability of LCA. The higher brain availability of LCA enabled CNS protection as evident from the increase in locomotor activity, improved motor coordination, and protection against drug-induced catatonia. In conclusion, FED offers an approach to repurpose LCA against Parkinsonism. This can encourage further investigation to simultaneously address hypertension and neurodegeneration.
Collapse
Affiliation(s)
- Bharat Bhusan Subudhi
- Drug Development and Analysis Lab., School of Pharmaceutical Sciences, Siksha O Anusandhan Deemed to be University, Ghatikia, Kalinganagar, Bhubaneswar, Odisha, 751029, India.
| | - Pratap Kumar Sahu
- Drug Development and Analysis Lab., School of Pharmaceutical Sciences, Siksha O Anusandhan Deemed to be University, Ghatikia, Kalinganagar, Bhubaneswar, Odisha, 751029, India
| | | | - Shaktiketan Prusty
- Drug Development and Analysis Lab., School of Pharmaceutical Sciences, Siksha O Anusandhan Deemed to be University, Ghatikia, Kalinganagar, Bhubaneswar, Odisha, 751029, India.
| |
Collapse
|
6
|
Jiao Q, Wang R, Jiang Y, Liu B. Study on the interaction between active components from traditional Chinese medicine and plasma proteins. Chem Cent J 2018; 12:48. [PMID: 29728878 PMCID: PMC5935606 DOI: 10.1186/s13065-018-0417-2] [Citation(s) in RCA: 26] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2017] [Accepted: 04/24/2018] [Indexed: 02/06/2023] Open
Abstract
Traditional Chinese medicine (TCM), as a unique form of natural medicine, has been used in Chinese traditional therapeutic systems over two thousand years. Active components in Chinese herbal medicine are the material basis for the prevention and treatment of diseases. Research on drug-protein binding is one of the important contents in the study of early stage clinical pharmacokinetics of drugs. Plasma protein binding study has far-reaching influence on the pharmacokinetics and pharmacodynamics of drugs and helps to understand the basic rule of drug effects. It is important to study the binding characteristics of the active components in Chinese herbal medicine with plasma proteins for the medical science and modernization of TCM. This review summarizes the common analytical methods which are used to study the active herbal components-protein binding and gives the examples to illustrate their application. Rules and influence factors of the binding between different types of active herbal components and plasma proteins are summarized in the end. Finally, a suggestion on choosing the suitable technique for different types of active herbal components is provided, and the prospect of the drug-protein binding used in the area of TCM research is also discussed.
Collapse
Affiliation(s)
- Qishu Jiao
- School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, 102488, China
| | - Rufeng Wang
- School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, 102488, China
| | - Yanyan Jiang
- School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, 102488, China
| | - Bin Liu
- School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, 102488, China.
| |
Collapse
|
7
|
Bujacz A, Talaj JA, Zielinski K, Pietrzyk-Brzezinska AJ, Neumann P. Crystal structures of serum albumins from domesticated ruminants and their complexes with 3,5-diiodosalicylic acid. Acta Crystallogr D Struct Biol 2017; 73:896-909. [PMID: 29095162 PMCID: PMC5683013 DOI: 10.1107/s205979831701470x] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2017] [Accepted: 10/11/2017] [Indexed: 12/20/2022] Open
Abstract
Serum albumin (SA) is the most abundant protein in plasma and is the main transporter of molecules in the circulatory system of all vertebrates, with applications in medicine, the pharmaceutical industry and molecular biology. It is known that albumins from different organisms vary in sequence; thus, it is important to know the impact of the amino-acid sequence on the three-dimensional structure and ligand-binding properties. Here, crystal structures of ovine (OSA) and caprine (CSA) serum albumins, isolated from sheep and goat blood, are described, as well those of their complexes with 3,5-diiodosalicylic acid (DIS): OSA-DIS (2.20 Å resolution) and CSA-DIS (1.78 Å resolution). The ligand-free OSA structure was determined in the trigonal space group P3221 at 2.30 Å resolution, while that of CSA in the orthorhombic space group P212121 was determined at 1.94 Å resolution. Both albumins are also capable of crystallizing in the triclinic space group P1, giving isostructural crystals that diffract to around 2.5 Å resolution. A comparison of OSA and CSA with the closely related bovine serum albumin (BSA) shows both similarities and differences in the distribution of DIS binding sites. The investigated serum albumins from domesticated ruminants in their complexes with DIS are also compared with the analogous structures of equine and human serum albumins (ESA-DIS and HSA-DIS). Surprisingly, despite 98% sequence similarity, OSA binds only two molecules of DIS, whereas CSA binds six molecules of this ligand. Moreover, the binding of DIS to OSA and CSA introduced changes in the overall architecture of the proteins, causing not only different conformations of the amino-acid side chains in the binding pockets, but also a significant shift of the whole helices, changing the volume of the binding cavities.
Collapse
Affiliation(s)
- Anna Bujacz
- Institute of Technical Biochemistry, Faculty of Biotechnology and Food Sciences, Lodz University of Technology, Stefanowskiego 4/10, 90-924 Lodz, Poland
| | - Julita A. Talaj
- Institute of Technical Biochemistry, Faculty of Biotechnology and Food Sciences, Lodz University of Technology, Stefanowskiego 4/10, 90-924 Lodz, Poland
| | - Kamil Zielinski
- Institute of Technical Biochemistry, Faculty of Biotechnology and Food Sciences, Lodz University of Technology, Stefanowskiego 4/10, 90-924 Lodz, Poland
| | - Agnieszka J. Pietrzyk-Brzezinska
- Institute of Technical Biochemistry, Faculty of Biotechnology and Food Sciences, Lodz University of Technology, Stefanowskiego 4/10, 90-924 Lodz, Poland
| | - Piotr Neumann
- Institute of Microbiology and Genetics, Department for Molecular Structural Biology, GZMB, Justus-von-Liebig Weg 11, 37077 Göttingen, Germany
| |
Collapse
|
8
|
Farcaş E, Pochet L, Crommen J, Servais AC, Fillet M. Capillary electrophoresis in the context of drug discovery. J Pharm Biomed Anal 2017; 144:195-212. [DOI: 10.1016/j.jpba.2017.02.022] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2016] [Revised: 02/04/2017] [Accepted: 02/13/2017] [Indexed: 01/07/2023]
|